newsfilter
← Latest News
GlobeNewswire·

CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right

SAN CARLOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. ("CARGO" or the "Company") (NASDAQ:CRGX), a biotechnology company that has focused on developing CAR T-cell therapies, today announced that